MRCLEAN - REGISTRY CRF ON PAPER. Study number: Inclusion date: Data entry date: / / Signature: Version 14.0 CJC/MK/RJG/DD/CM/JB January 2019

Similar documents
what do the numbers really mean? NIHSS Timothy Hehr, RN MA Stroke Program Outreach Coordinator Allina Health

MRCLEAN REGISTRY CRF ON PAPER. Study number: Inclusion date: Data entry date: / / Signature: Version 12.0 IGHJ/RG/MM/DD/OB/CM February 2017

MRCLEAN - REGISTRY CRF ON PAPER. Study number: Inclusion date: Data entry date: / / Signature: Version 11.0 IGHJ/DD/OB/CM November 2015

SARASOTA MEMORIAL HOSPITAL. NURSING PROCEDURE NATIONAL INSTITUTE OF HEALTH STROKE SCALE (neu04) Nursing

Thrombolysis Assessment

Stroke Transfer Checklist

ACCESS CENTER:

Case Report Forms (CRFs) ON PAPER

NIHSS. Category Scale Definition Date/Time Date/Time Date/Time. Score Initial. Drip & Ship Protocol. Initials: Signature: Initials: Signature:

ED Stroke Panel Page 1 of 2

o Unenhanced Head CT

Thrombolysis for acute ischaemic stroke Rapid Assessment Protocol NORTHERN IRELAND Regional Protocol (Version 002 July 08)

Patient Care Orders for CODE STROKE: alteplase Administration order set for Acute Ischemic Stroke less than 4.5 hours

/ / / / / / Hospital Abstraction: Stroke/TIA. Participant ID: Hospital Code: Multi-Ethnic Study of Atherosclerosis

DATA COLLECTION FORMS PARTICIPATING SITES

AGWS Stroke Thrombolysis Clinical Profoma

Call the Transfer Line at (216)

Endovascular Neurointervention in Cerebral Ischemia

Comparison of Five Major Recent Endovascular Treatment Trials

Endovascular Treatment Updates in Stroke Care

Stroke Oxygen Study Randomisation Form

ACUTE ISCHEMIC STROKE. Current Treatment Approaches for Acute Ischemic Stroke

UPDATES IN INTRACRANIAL INTERVENTION Jordan Taylor DO Metro Health Neurology 2015

Better identification of patients who may benefit from therapy

Page 1 of 7. Intraparenchymal hemorrhage or subarachnoid hemorrhage. Consult neurosurgery

Size Matters: Differentiating Large Vessel Occlusion (LVO) and Small Vessel Occlusion (SVO) in Stroke

Code Stroke in real life. Disclosures. Parkland Memorial Hospital. I have no disclosures. Has 1 million patient visits annually. Level 1 Trauma Center

GUIDELINES FOR THE EARLY MANAGEMENT OF PATIENTS WITH ACUTE ISCHEMIC STROKE

TIA AND STROKE. Topics/Order of the day 1. Topics/Order of the day 2 01/08/2012

Stroke School for Internists Part 1

Shands at the University of Florida Stroke Program

Mechanical Thrombectomy of Large Vessel Occlusions Using Stent Retriever Devices

Objectives. Stroke Facts 2/27/2015. EMS in Stroke Care: A Critical Partnership

Primary Stroke Center Acute Stroke Transfer Guidelines When to Consider a Transfer:

ABNORMAL STROKE EXAM FINDINGS:

Overview. Introduction. New Interventions for Acute Stroke. New Approaches to hemorrhagic Strokes

Alan Barber. Professor of Clinical Neurology University of Auckland

Top 5 Big Things in Acute Stroke Care! Raymond W. Grams II, DO Vascular Neurology Stroke Medical Director DRMC, Intermountain Healthcare

Heart of England Foundation Trust ACUTE STROKE PATHWAY EMERGENCY DEPARTMENT ATTACHMENTS

CKET GUIDE STROKE ASSESSMENT POCKET GUIDE S

The Neurological System. Neurological Exam 5 Components. Mental Status Examination

Activase Therapy for Acute Ischemic Stroke Management

As seen in Cath Lab Digest In the Unlikely Event: Optimal Care Strategies for Stroke in the Cath Lab

Basilar artery stenosis with bilateral cerebellar strokes on coumadin

Endovascular Treatment for Acute Ischemic Stroke: Curtis A. Given II, MD Co-Director, Neurointerventional Services Baptist Physician Lexington

PEDIATRIC ARTERIAL ISCHEMIC STROKE (AIS)

10/13/2017. AllinaHealthSystems. Stroke Recognition Sandra K Hanson, MD Medical Director United Hospital Stroke Program

Hywel Dda Health Board Stroke Thrombolysis Care Pathway (Pembrokeshire version)

PATIENT S NOTES History and Physical Brain Attack Stroke

Acute Stroke Treatment: Current Trends 2010

5/31/2018. Interventional Therapies that Expand Time Windows for Acute Ischemic Stroke Treatment. Disclosures. Impact of clot burden

PEDIATRIC ARTERIAL ISCHEMIC STROKE (AIS)

Thrombectomy with the preset stent-retriever. Insights from the ARTESp* trial

ACUTE STROKE. Internal Medicine Lecture July 17, 2018

Table 3.1: Canadian Stroke Best Practice Recommendations Screening and Assessment Tools for Acute Stroke Severity

Canadian Stroke Best Practices Table 3.3A Screening and Assessment Tools for Acute Stroke

CEREBRO VASCULAR ACCIDENTS

Redgrave JN, Coutts SB, Schulz UG et al. Systematic review of associations between the presence of acute ischemic lesions on

Mechanical thrombectomy beyond the 6 hours. Mahmoud Rayes, MD Medical Director, Stroke program Greenville Memorial Hospital

Stroke: clinical presentations, symptoms and signs

BY: Ramon Medina EMT-LP/RN

Acute Stroke Management LUKE BRADBURY, MD 10/8/14 FALL WAPA CONFERENCE

Carotid Embolectomy and Endarterectomy for Symptomatic Complete Occlusion of the Carotid Artery as a Rescue Therapy in Acute Ischemic Stroke

: STROKE. other pertinent information such as recent trauma, illicit drug use, pertinent medical history or use of oral contraceptives.

Canadian Stroke Best Practices Initial ED Evaluation of Acute Stroke and Transient Ischemic Attack (TIA) Order Set (Order Set 1)

Code Stroke Intervention: Endovascular Therapies for Stroke J. DIEGO LOZANO MD INTERVENTIONAL NEURORADIOLOGY

Distal Mechanical Thrombectomy in Acute Ischemic Stroke Method and Benefit. Hans Henkes, Wiebke Kurre Stuttgart, Germany

11/23/2015. Disclosures. Stroke Management in the Neurocritical Care Unit. Karel Fuentes MD Medical Director of Neurocritical Care.

CARES Targeted Temperature Management (TTM) Module

BGS Spring Conference 2015

Management of Acute Ischemic Stroke. Learning Objec=ves. What is a Stroke? Jen Simpson Neurohospitalist

ENDOVASCULAR THERAPIES FOR ACUTE STROKE

Mechanical Thrombectomy: Where Are We Now? T. Adam Oliver, MD Tallahassee Neurological Clinic Tallahassee, Florida TMH Neurosymposium June 11, 2016

CVA Updates Karen Greenberg, DO, FACOEP. Director Neurologic Emergency Department Crozer Chester Medical Center

Stroke & the Emergency Department. Dr. Barry Moynihan, March 2 nd, 2012

TENNESSEE STROKE REGISTRY QUARTERLY REPORT

Advances in Neuro-Endovascular Care for Acute Stroke

Stroke Update Elaine J. Skalabrin MD Medical Director and Neurohospitalist Sacred Heart Medical Center Stroke Center

How to Interpret CT/CTA for Acute Stroke in the Age of Endovascular Clot Retrieval

Emergency Department Management of Acute Ischemic Stroke

Alan Barber. Professor of Clinical Neurology University of Auckland

Unclogging The Pipes. Zahraa Rabeeah MD Chief Resident February 9,2018

57y WRH woman, controlled HTN only, presents with sudden LOC, fixed and dilated, quadraplegic Intubated on arrival and CT is negative CTA and CTP

ND STROKE Coordinators Case Studies. STEMI and Stroke Conference, Fargo, ND, August 5, 2014

Mechanical Endovascular Reperfusion Therapy

Neuro-vascular Intervention in Stroke. Will Adams Consultant Neuroradiologist Plymouth Hospitals NHS Trust

TRAUMATIC CAROTID &VERTEBRAL ARTERY INJURIES

Vivek R. Deshmukh, MD Director, Cerebrovascular and Endovascular Neurosurgery Chairman, Department of Neurosurgery Providence Brain and Spine

Stroke in the ED. Dr. William Whiteley. Scottish Senior Clinical Fellow University of Edinburgh Consultant Neurologist NHS Lothian

<INSERT COUNTRY/SITE NAME> All Stroke Events

Neurocritical Care Basics. Tapan Kavi, MD Christina Fox, RN

ACUTE STROKE INTERVENTION: THE ROLE OF THROMBECTOMY AND IA LYSIS

Case. Learning objectives. NIHSS values. Presenter Disclosure Information

Stroke Clinical Trials Update Transitioning to an Anatomic Diagnosis in Ischemic Stroke

Intended Learning Outcomes

I n t e r h o s p i t a l Tr a n s fe r s o f t h e A c u t e S t r o ke Pat i e n t E M S G r a n d Ro u n d s : Febr u a r y 2 1,

IDPH EMS Region Five. Stroke Education

Pathophysiology of stroke

The Neurologic Examination: High-Yield Strategies

ELVO update. Michael Wilder, MD Director, Neurointerventional Program PeaceHealth Sacred Heart Springfield, Oregon

Transcription:

MRCLEAN - REGISTRY CRF ON PAPER Version 14.0 CJC/MK/RJG/DD/CM/JB January 2019 Study number: Inclusion date:. / / Data entry date: / / Signature:

INSTRUCTIE: Wij vragen u het formulier zo volledig mogelijk in te vullen. Zeer belangrijk is het tevens invullen van de gegevens in de digitale MR CLEAN-Registry database, bereikbaar via www.mrclean-trial.org. De papieren versie is een werkdocument en kan lokaal bewaard worden. Wij danken u voor medewerking aan de MR CLEAN Registry. Met vriendelijke groet, MR CLEAN-Registry Trial Office Fax: 010-7044721 Email: mrclean@erasmusmc.nl

BASELINE Inclusion criteria MR CLEAN-Registry 1. Clinical diagnosis of acute stroke? No Yes 4. Retrospective informed consent given No Yes 2. Intracranial arterial occlusion of the distal intracranial carotid artery, anterior (A1/A2), middle (M1/M2) cerebral artery or posterior cerebral artery (VA/BA/P1) (demonstrated with CTA, MRA, DSA) 3. Patient treated with intra-arterial therapy No Yes 5. Are all above criteria met? No Yes No Yes If not, please still include patient in MR CLEAN Registry but do not follow up Timing of baseline procedures (missing code=9999) Time arrival ER (first hospital) hh:mm Time of 1: last seen well or 2: onset Time: hh:mm Time plain CT (first hospital) hh:mm Inhospital patient? No Yes Time CTA (first hospital) hh:mm Transfer from other hospital? No Yes Name hospital: Time arrival ER (intervention hospital) hh:mm Patient treated with alteplase No Yes Dose: mg Time plain CT (intervention hospital) hh:mm Time start of start alteplase (if given) hh:mm Time CTA (intervention hospital) hh:mm Contra-indications for alteplase No Yes If yes, please specify: History Previous ischemic stroke No Yes Unk Diabetes Mellitus No Yes Unk Antiplatelet use No Yes Unk If yes, in same arterial distribution as current stroke? No Yes Unk Hypertension No Yes Unk Use of new oral anticoagulants (NOA s) No Yes Unk Intra-cranial hemorrhage No Yes Unk Atrial fibrillation No Yes Unk Use of coumarines No Yes Unk Severe head injury No Yes Unk Hypercholesterolemia No Yes Unk Use of heparin(oid) No Yes Unk Myocardial infarction No Yes Unk Smoking No Yes Unk Use of antihypertensive No Yes Unk drugs Peripheral arterial disease No Yes Unk Use of statins No Yes Unk Glasgow Coma Score(GCS) Eye GCS Motor GCS Verbal Metrics 4 Opens eyes spontaneously 6 Obeys commands 5 Oriented/converses normally Systolic BP mm Hg 3 Opens eyes in response to voice 5 Localizes painful stimuli 4 Confused/disoriented Diastolic BP mm Hg 2 Opens eyes in response to painful stimuli 4 Flexion/withdrawal to painful 3 Utters inappropriate words Height cm stimuli 1 Does not open eyes 3 Abnormal flexion to painful stimuli 2 Incomprehensible sounds Body degrees C temperature 2 Extension to painful stimuli 1 No sounds Weight kg 1 No movements Imaging modality Performed Sent to AMC 1. Non-contrast CT No Yes Yes No Date of scan / / (dd/mm/yyyy) Referring hospital please specify: Performed in: Intervention hospital Both please specify referring hospital: - 2.CTA No Yes Yes No Performed in: Referring hospital please specify: Intervention hospital Both please specify referring hospital: 3.CT-Perfusion No Yes Yes No 4.MR (DWI) No Yes Yes No 5.MRA No Yes Yes No SERIOUS ADVERSE EVENTS (SAE) CHECK Did the patient experience a serious adverse event in this episode? No Yes (if yes, please complete SAE-form on final page) Pre-stroke mrs Lab Information (missing code = 9999) 0 No symptoms INR 1 Minor symptoms, no limitations Thrombocyte count x10^9/l 2 Slight disability, no help needed Serum Creatinine umol/l 3 Moderate disability, still independent CRP mg/l 4 Moderately severe disability Serum Glucose mmol/l 5 Severe disability, completely dependent Comorbidity influencing mrs? No Yes, please specify:

NIH STROKE SCALE (NIHSS) Please fill out the NIHSS twice: at baseline and after 24-48 hours. For each item, an additional explanation is given on the next page. Study number:....................................... Inclusion date: / / (dd-mm-yyyy) Date: Time: Physician: BASELINE 24-48 HOURS Date: Time: Physician: Item: Description: Score: Score: 1a Level of consciousness. 0 = alert. 1 = not alert, but arousable by minor stimulation to obey, answer, or respond. 2 = not alert, requires repeated stimulation to attend, or is obtunded and requires strong or painful stimulation to make movements (not stereotyped). 3 = coma (unresponsive). 1b LOC questions. 0 = answers both questions correctly. 1 = answers one question correctly. 2 = answers neither question correctly. 1c LOC commands. 0 = performs both tasks correctly. 1= performs one task correctly. 2 = performs neither tasks correctly. 2 Gaze. 0 = normal 1 = partial gaze palsy. This score is given when gaze is abnormal in one or both eyes, but where forced deviation or total gaze paresis are not present. 2 = forced deviation, or total gaze paresis not overcome by the oculocephalic maneuver. 3 Visual. 0 = no visual loss. 1 = partial hemianopia. 2 = complete hemianopia. 3 = bilateral hemianopia (blind, including cortical blindness) 4 Facial palsy. 0 = normaal/symmetrical. 1 = minor paralysis (flattened nasolabial fold, asymmetry on smiling) 2 = partial paralysis (total or near total paralysis of lower face) 3 = complete paralysis of one or both sides (absence of facial movement in the upper and lower face) 5a Motor function. 0 = no drift, limb holds 90 for full 10 seconds. Left arm. 1 = drift, Limb holds 90, but drifts down before full 10 seconds 2 = some effort against gravity, limb cannot get to or maintain 90 3 = no effort against gravity, limb falls. 4 = no movement 9 = untestable (e.g. amputation); elaborate: 5b Motor function. 0 = no drift, limb holds 90 for full 10 seconds. Right arm. 1 = drift, Limb holds 90, but drifts down before full 10 seconds 2 = some effort against gravity, limb cannot get to or maintain 90 3 = no effort against gravity, limb falls. 4 = no movement 9 = untestable (e.g. amputation); elaborate: 6a Motor function 0 = no drift, leg holds 30 position for full 5 seconds. Left leg 1 = drift, leg falls by the end of the 5 second period. 2 = some effort against gravity; leg falls to bed by 5 seconds. 3 = no effort against gravity, leg falls to bed immediately. 4 = no movement. 9 = untestable (e.g. amputation); elaborate: 6b Motor function. 0 = no drift, leg holds 30 position for full 5 seconds. Right leg. 1 = drift, leg falls by the end of the 5 second period. 2 = some effort against gravity; leg falls to bed by 5 seconds. 3 = no effort against gravity, leg falls to bed immediately. 4 = no movement. 9 = untestable (e.g. amputation); elaborate: 7 Limb ataxia. 0 = absent. 1 = present in one limb. 2 = present in two limbs. 8 Sensory. 0 = normal. 1 = mild to moderate sensory loss. 2 = severe to total sensory loss. 9 Language. 0 = no aphasia 1 = mild tot moderate aphasia. 2 = severe aphasia. 3 = mute, global aphasia; no usable speech or auditory comprehension. 10 Dysarthria. 0 = normal articulation 1 = mild to moderate; patient can be understood with some difficulty. 2 = Severe; patient's speech is unintelligible in the absence of or out of proportion to any dysphasia, or is mute. 9 = Intubated or other physical barrier; elaborate:.. 11 Extinction and inattention. 0 = no abnormality 1 = visual, tactile, auditory, spatial, or personal inattention or extinction. 2 = profound hemi-inattention or hemi-inattention to more than one modality.. Total score:

1a. Level of Consciousness: the investigator must choose a response, even if a full evaluation is prevented by such obstacles as an endotracheal tube, language barrier, orotracheal trauma/bandages. A 3 is scored only if the patient makes no movement (other than reflexive posturing) in response to noxious stimulation. 1b. LOC Questions: the patient is asked the month and his/her age. The answer must be correct - there is no partial credit for being close. Aphasic and stuporous patients who do not comprehend the questions will score 2. Patients unable to speak because of endotracheal intubation, orotracheal trauma, severe dysarthria from any cause, language barrier or any other problem not secondary to aphasia are given a 1. It is important that only the initial answer be graded and that the examiner not "help" the patient with verbal or non-verbal cues. 1c. LOC Commands: the patient is asked to open and close the eyes and then to grip and release the non-paretic hand. Substitute another one step command if the hands cannot be used. Credit is given if an unequivocal attempt is made but not completed due to weakness. If the patient does not respond to command, the task should be demonstrated to them (pantomime) and score the result (i.e., follows none, one or two commands). Patients with trauma, amputation, or other physical impediments should be given suitable one-step commands. Only the first attempt is scored. 2. Gaze: only horizontal eye movements will be tested. Voluntary or reflexive (oculocephalic) eye movements will be scored but caloric testing is not done. If the patient has a conjugate deviation of the eyes that can be overcome by voluntary or reflexive activity, the score will be 1. If a patient has an isolated peripheral nerve paresis (CN III, IV or VI) score a 1. Gaze is testable in all aphasic patients. Patients with ocular trauma, bandages, pre-existing blindness or other disorder of visual acuity or fields should be tested with reflexive movements and a choice made by the investigator. Establishing eye contact and then moving about the patient from side to side will occasionally clarify the presence of a partial gaze palsy. 3. Visual: visual fields (upper and lower quadrants) are tested by confrontation, using finger counting or visual threat as appropriate. Patient must be encouraged, but if they look at the side of the moving fingers appropriately, this can be scored as normal. If there is unilateral blindness or enucleation, visual fields in the remaining eye are scored. Score 1 only if a clear-cut asymmetry, including quadrantanopia is found. If patient is blind from any cause score 3. Double simultaneous stimulation is performed at this point. If there is extinction patient receives a 1 and the results are used to answer question 11. 4. Facial palsy: ask, or use pantomime to encourage the patient to show teeth or raise eyebrows and close eyes. Score symmetry of grimace in response to noxious stimuli in the poorly responsive or non-comprehending patient. If facial trauma/bandages, orotracheal tube, tape or other physical barrier obscures the face, these should be removed to the extent possible. 5 & 6. Motor function arm and Leg: the limb is placed in the appropriate position: extend the arms (palms down) 90 degrees (if sitting) or 45 degrees (if supine) and the leg 30 degrees (always tested supine). Drift is scored if the arm falls before 10 seconds or the leg before 5 seconds. The aphasic patient is encouraged using urgency in the voice and pantomime but not noxious stimulation. Each limb is tested in turn, beginning with the nonparetic arm. Only in the case of amputation or joint fusion at the shoulder or hip may the score be "9" and the examiner must clearly write the explanation for scoring as a "9". 7. Limb Ataxia: this item is aimed at finding evidence of a unilateral cerebellar lesion. Test with eyes open. In case of visual defect, insure testing is done in intact visual field. The finger-nose-finger and heel-shin tests are performed on both sides, and ataxia is scored only if present out of proportion to weakness. Ataxia is absent in the patient who cannot understand or is paralyzed. Only in the case of amputation or joint fusion may the item be scored "9", and the examiner must clearly write the explanation for not scoring. In case of blindness test by touching nose from extended arm position. 8. Sensory: sensation or grimace to pin prick when tested, or withdrawal from noxious stimulus in the obtunded or aphasic patient. Only sensory loss attributed to stroke is scored as abnormal and the examiner should test as many body areas [arms (not hands), legs, trunk, face] as needed to accurately check for hemisensory loss. A score of 2, "severe or total," should only be given when a severe or total loss of sensation can be clearly demonstrated. Stuporous and aphasic patients will therefore probably score 1 or 0. The patient with brain stem stroke who has bilateral loss of sensation is scored 2. If the patient does not respond and is quadriplegic score 2. Patients in coma (item 1a = 3) are arbitrarily given a 2 on this item. 9. Best language: a great deal of information about comprehension will be obtained during the preceding sections of the examination. The patient is asked to describe what is happening in the attached picture, to name the items on the attached naming sheet, and to read from the attached list of sentences. Comprehension is judged from responses here as well as to all of the commands in the preceding general neurological exam. If visual loss interferes with the tests, ask the patient to identify objects placed in the hand, repeat, and produce speech. The intubated patient should be asked to write. The patient in coma (question 1a=3) will arbitrarily score 3 on this item. The examiner must choose a score in the patient with stupor or limited cooperation but a score of 3 should be used only if the patient is mute and follows no one step commands. 10. Dysarthria: if patient is thought to be normal an adequate sample of speech must be obtained by asking patient to read or repeat words from the attached list. If the patient has severe aphasia, the clarity of articulation of spontaneous speech can be rated. Only if the patient is intubated or has other physical barrier to producing speech, may the item be scored "9", and the examiner must clearly write an explanation for not scoring. Do not tell the patient why he/she is being tested. 11. Extinction and inattention (formerly Neglect ): sufficient information to identify neglect may be obtained during the prior testing. If the patient has a severe visual loss preventing visual double simultaneous stimulation, and the cutaneous stimuli are normal, the score is normal. If the patient has aphasia but does appear to attend to both sides, the score is normal. The presence of visual spatial neglect or anosagnosia may also be taken as evidence of abnormality. Since the abnormality is scored only if present, the item is never untestable.

MRCLEAN-R: INTERVENTION CASE REGISTRATION FORM Date: / / (dd/mm/yyyy) 1 st interventionalist: 2 nd interventionalist:. 3 rd interventionalist:.. Paste patient sticker or write down: Name: Gender: Patient #: Birth date: 1. Intervention Catheterization only DSA only Intervention If no intervention is performed, please explain: 2. etici-score before intra-arterial treatment: 0: No perfusion or antegrade flow beyond site of occlusion 1: Penetration but not perfusion. Contrast penetration exists past the initial obstruction but with minimal filling of the normal territory 2A: Some perfusion with distal branch filling of <50% of territory vascularized 2B: Substantial perfusion with distal branch filling of 50% of territory visualized 2C: Near-complete perfusion except for slow flow in a few distal cortical vessels or presence of small distal cortical emboli 3: Complete perfusion with normal filling of all distal branches 3. Location of occlusion: M1 M2 A1 A2 ICA ICA-T VA BA P1 other: Side: Left Right 4a. General anesthesia during procedure: no yes 4b. Conscious sedation during procedure: no yes 5. Medication administered during procedure: heparin Total dose: IU abciximab (Reopro) Total dose:.. mg other. Total dose: 6. Treatment with mechanical device: Guiding catheter: 6F 8F Balloon: no yes Stent-retriever: Solitaire attempts: Revive attempts: Catch attempts: TREVO attempts: Other:...... attempts: Aspiration device: attempts: MERCI -retriever attempts: Other: attempts: Please specify which stent was used first:. ATTENTION: TURN OVER! Please fill out backside as well!

7. Treatment with intra-arterial thrombolytic: no urokinase, dose: alteplase, dose:. 8. Time - Arrival patient in angio-suite:.. (hh:mm) - Groin puncture:.. - First attempt with device:.. - Time of first recanlization (TICI 2b/3) or last contrast bolus:.. - Sheath from groin:.. - Total duration of IA treatment (groin puncture to sheath withdrawal).. minutes 9. Thrombus extracted for PA: no yes 10. etici-score after intra-arterial treatment: 0: No perfusion 1: Antegrade reperfusion past the initial occlusion, but limited distal branch filling with little or slow distal reperfusion 2A: Antegrade reperfusion of less than half of the occluded target artery previously ischemic territory (e.g. in 1 major division of the MCA and its territory) 2B: Antegrade reperfusion of more than half of the previously occluded target artery ischemic territory (e.g. in 2 major divisions of the MCA and their territories) 2C: Near-complete perfusion except for slow in a few distal cortical vessels or presence of small distal cortical emboli 3: Complete antegrade reperfusion of the previously occluded target artery ischemic territory, with absence of visualized occlusion in all branches 11. Procedural complications / adverse events (e.g. vasospasm, dissection, perforation or peripheral emboli): 12. Description of procedure (optional): 13. Closure device used: angioseal other, please specify type: Side: Left Right 14. Have all images been transferred to the PACS system? Please include baseline & post-intervention AP + lateral imaging up until venous phase. 15. Signature: Date: / / (dd/mm/yyyy)

Post-intervention IMAGING Performed? No Yes If YES, please fill in below: IMAGING #1 Date of scan / / (dd/mm/yyyy) Sent to AMC: Yes Not applicable Modality Non-contrast CT No Yes MRA No Yes Other: CTA No Yes MR (DWI) No Yes Hemorrhage No Yes Hemorrhagic transformation No Yes IMAGING #2 Date of scan / / (dd/mm/yyyy) Sent to AMC: Yes Not applicable Modality Non-contrast CT No Yes MRA No Yes Other: CTA No Yes MR (DWI) No Yes Hemorrhage No Yes Hemorrhagic transformation No Yes IMAGING #3 Date of scan / / (dd/mm/yyyy) Sent to AMC: Yes Not applicable Modality Non-contrast CT No Yes MRA No Yes Other: CTA No Yes MR (DWI) No Yes Hemorrhage No Yes Hemorrhagic transformation No Yes ADMISSION TO ICU / MC / STROKE UNIT Was the patient admitted to ICU No Yes Total number of days in ICU Was the patient admitted to High Care No Yes Total number of days in High Care Was the patient admitted to stroke unit No Yes Total number of days in stroke unit DISCHARGE Discharge date from endovascular treatment hospital or date of death: / / (dd/mm/yyyy) Discharge destination Own home Nursing home, name & city: Hospital, name & city: Rehabilitation center, name & city: Other, name & city: SERIOUS ADVERSE EVENTS (SAE) CHECK Did the patient experience a serious adverse event in this episode? No Yes (if yes, please complete SAE-form on final page)

3 MONTH FOLLOW UP Date / / Questions answered by: Patient Other, Patient information Patient residential status Own home Nursing home, name: Hospital, name: Rehabilitation center, name: Number of readmissions to hospital Hospital name(s): 1. 2. 3 month mrs 0 No symptoms 1 Minor symptoms, no limitations 2 Slight disability, no help needed 3 Moderate disability, still independent 4 Moderately severe disability 5 Severe disability, completely dependent 6 Death, date of death: / / (dd / mm / yyyy) Reason: Admission planned before stroke event? No Yes Remarks: Comorbidity influencing mrs? No Yes, please specify:

SERIOUS ADVERSE EVENTS (SAE) FORM 1 Study number: Physician name: Date of SAE onset: Physician signature: Date of SAE resolution: Phase of occurence: Baseline Peri-interventional Within 24 hours Between 24 hours and 48 hours Between 48 hours and discharge Between discharge and 3 month follow up Date of SAE registration: / / (dd / mm / yyyy) Please fill out the SAE flow chart: No further action required No Serious adverse event (SAE) or event possibly related to IAT? Yes A serious adverse event (SAE) is any untoward medical occurrence or effect causing: mortality a life-threatening situation prolonged hospitalization persistent significant disability. Yes Neurologic deterioration 4 points on NIHSS No Cause(s) for SAE: Stroke progression New ischemic stroke Intra-cranial hemorrhage Extra-cranial hemorrhage Cardiac ischemia Allergic reaction Pneumonia Other infection: Other: Unknown Relationship with intra-arterial therapy: No Unlikely Possible Probable Definite Actions regarding intra-arterial therapy: None Interrupted Discontinued Other: Outcome of SAE: Resolved without sequelae Resolved with sequelae: disability prolonged hospital stay life threatening illness Ongoing (pending) Death, date: / / (dd/mm/yyyy)

SERIOUS ADVERSE EVENTS (SAE) FORM 2 Study number: Physician name: Date of SAE onset: Physician signature: Date of SAE resolution: Phase of occurence: Baseline Peri-interventional Within 24 hours Between 24 hours and 48 hours Between 48 hours and discharge Between discharge and 3 month follow up Date of SAE registration: / / (dd / mm / yyyy) Please fill out the SAE flow chart: No further action required No Serious adverse event (SAE) or event possibly related to IAT? Yes A serious adverse event (SAE) is any untoward medical occurrence or effect causing: mortality a life-threatening situation prolonged hospitalization persistent significant disability. Yes Neurologic deterioration 4 points on NIHSS No Cause(s) for SAE: Stroke progression New ischemic stroke Intra-cranial hemorrhage Extra-cranial hemorrhage Cardiac ischemia Allergic reaction Pneumonia Other infection: Other: Unknown Relationship with intra-arterial therapy: No Unlikely Possible Probable Definite Actions regarding intra-arterial therapy: None Interrupted Discontinued Other: Outcome of SAE: Resolved without sequelae Resolved with sequelae: disability prolonged hospital stay life threatening illness Ongoing (pending) Death, date: / / (dd/mm/yyyy)

SERIOUS ADVERSE EVENTS (SAE) FORM 3 Study number: Physician name: Date of SAE onset: Physician signature: Date of SAE resolution: Phase of occurence: Baseline Peri-interventional Within 24 hours Between 24 hours and 48 hours Between 48 hours and discharge Between discharge and 3 month follow up Date of SAE registration: / / (dd / mm / yyyy) Please fill out the SAE flow chart: No further action required No Serious adverse event (SAE) or event possibly related to IAT? Yes A serious adverse event (SAE) is any untoward medical occurrence or effect causing: mortality a life-threatening situation prolonged hospitalization persistent significant disability. Yes Neurologic deterioration 4 points on NIHSS No Cause(s) for SAE: Stroke progression New ischemic stroke Intra-cranial hemorrhage Extra-cranial hemorrhage Cardiac ischemia Allergic reaction Pneumonia Other infection: Other: Unknown Relationship with intra-arterial therapy: No Unlikely Possible Probable Definite Actions regarding intra-arterial therapy: None Interrupted Discontinued Other: Outcome of SAE: Resolved without sequelae Resolved with sequelae: disability prolonged hospital stay life threatening illness Ongoing (pending) Death, date: / / (dd/mm/yyyy)